Strategic Investment Solutions’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.3K Hold
200
0.01% 327
2026
Q1
$27.9K Hold
200
0.01% 302
2025
Q4
$24.5K Buy
+200
New +$24.3K 0.01% 302
2025
Q2
Sell
-341
Closed -$38.2K 634
2025
Q1
$38.2K Buy
341
+15
+5% +$1.55K 0.01% 225
2024
Q4
$26.4K Sell
326
-10
-3% -$900 0.01% 280
2024
Q3
$28.1K Sell
336
-112
-25% -$8.55K 0.01% 245
2024
Q2
$33.4K Buy
+448
New +$29.9K 0.01% 214
2023
Q4
$26.4K Sell
326
-5,194
-94% -$404K ﹤0.01% 608
2023
Q3
$428K Buy
5,520
+5,405
+4,700% +$416K 0.01% 414
2023
Q2
$8.79K Sell
115
-316
-73% -$25.2K ﹤0.01% 576
2023
Q1
$35.8K Buy
+431
New +$35.7K 0.01% 427

Other funds holding GILD

Strategic Investment Solutions's GILD Position: Q2 2026 in Review

Strategic Investment Solutions held its Gilead Sciences (GILD) position steady in Q2 2026 at 200 shares worth $25.3K. The position accounts for 0.01% of the portfolio, ranked #327.

Strategic Investment Solutions first reported a position in GILD in Q1 2023 and has held it in 11 quarters since. The position peaked at $428K in Q3 2023. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Strategic Investment Solutions held 200 shares of Gilead Sciences worth $25.3K as of Q2 2026.
  • Strategic Investment Solutions left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.01% of Strategic Investment Solutions's portfolio in Q2 2026, its #327 holding.
  • Strategic Investment Solutions first reported a position in Gilead Sciences in Q1 2023 and has held it in 11 quarters since.
  • Strategic Investment Solutions's Gilead Sciences position peaked at $428K in Q3 2023.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Strategic Investment Solutions's 13F filing for Q2 2026, filed 8 Jul 2026.